General Information of the Compound
| Compound ID |
CP0168682
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-Pyridin-3-yl-benzo[h]chromen-4-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
1939-53-3
2-(pyridin-3-yl)-4H-benzo[h]chromen-4-one
2-Pyridin-3-yl-benzo[h]chromen-4-one
2-pyridin-3-ylbenzo[h]chromen-4-one
4H-Naphtho[1,2-b]pyran-4-one, 2-(3-pyridinyl)-
AC1L88Q3
BDBM50159611
CHEMBL177938
CTK0E1147
DTXSID00314472
MLS000757116
NSC-283845
NSC283845
SMR000449783
TX-011635
ZINC13143019
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H11NO2
|
||||||||||||||||||
| Molecular Weight |
273.291
|
||||||||||||||||||
| Canonical SMILES |
O=c1cc(oc2c3ccccc3ccc12)-c1cccnc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H11NO2/c20-16-10-17(13-5-3-9-19-11-13)21-18-14-6-2-1-4-12(14)7-8-15(16)18/h1-11H
Show/Hide
|
||||||||||||||||||
| InChIKey |
RURRJHXFMININK-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
1939-53-3
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00955, DNA-dependent protein kinase catalytic subunit
Protein ID: PT06109, Geminin
Clinical Information about the Compound